MAPK3 and cancer: Research evidence also suggests that extracellular T4 and its extended T3 metabolite may initiate cancer cell proliferation across various malignancies by binding to plasma membrane integrin avβ3 receptors, which triggers the activation of ERK1/2 signaling cascades and downstream pathways (18).